AMP Limited – Resetting Business and Providing an Update on 1H 18 results

spark newsroom

AMP Limited’s (ASX: AMP) gave a media report in relation to taking action to reset the business operation and provided 1HFY18 updates. As per the media release, the group expects provision of A$290 Mn (post-tax) for potential advice remediation as a compensation for the consumers who lost their earnings because of poor advice for almost a decade. The management revealed that this provision will be included in the first half of the year results which could impact the bottom line of the company. Based on this, the company has estimated underlying profit of the company in the range of $490 Mn to $ 500 Mn in 1HFY18 as compared to $553 Mn in the prior corresponding period (pcp), marking de-growth of about 9.6% to 11.4% on pcp basis.

On the other hand, the management stated that they remain strongly capitalized and expected capital surplus over Minimum Regulatory Requirements of $1.8 Bn in 1HFY18 that includes the impacts of the advice remediation provision. Further, the group has set the target of total dividend payout ratio to be awarded its shareholders for FY18 at the lower end of the 70-90%.

With this news, the stock tumbled 4.6 per cent with the intra-trading volume of more than 32.94 million. Currently, it traded at $3.32 with the market-cap of circa $10.16 Bn as of July 27, 2018 before market close (AEST: 3:33 P.M.).

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report